ProCE Banner Activity

Addition of Pracinostat to Azacitidine in Previously Untreated MDS

Slideset Download
Conference Coverage
Randomized, placebo-controlled phase II trial evaluated this novel combination in patients with previously untreated MDS.

Released: December 15, 2015

Expiration: December 13, 2016

No longer available for credit.

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

Amgen, Inc.

Celgene

Incyte

Merck & Co., Inc.

Millennium Takeda

Seagen